ESMO Summit Middle East 2018

Dubai, United Arab Emirates - 06 Apr - 07 Apr 2018

The ESMO Summit Middle East 2018 is an educational event with presentations focused on several key disease sites. Created for oncology professionals in the Middle East by international and local key opinion leaders, the summit will put into context the most significant treatment advances.

 Summit objectives

  • To provide the oncology community with a summary of the most significant treatment advances
  • To review the current standard of care for key malignancies from a local and international perspective
  • To discuss the current controversies in the management of specific cancers

Discover the programme   Register here    More information

Target audience

Medical and clinical oncologists, pharmacists, nurses, students, fellows, residents, general practitioners in oncology and other oncology healthcare professionals.

Chairs

Rolf A. Stahel, CH
Shaheenah Dawood, UAE (local chair)

Faculty

  • Susana Banerjee, UK
  • Fortunato Ciardiello, IT
  • Ronald De Wit, NL
  • Kevin Harrington, UK
  • Stein Kaasa, NO
  • Rolf A. Stahel, CH
  • Josep Tabernero, ES
  • Eric Van Cutsem, BE
  • Hampig Raphael Kourie, LB
  • Shaheenah Dawood, UAE
  • Hamdy A. Azim, EG
  • Karim Elmasry, UAE
  • Fadi Farhat, LB
  • Mona Tareen, UAE
  • Diaeddine Trad, UAE
  • Mohammad Al Falasi, UAE
  • Shailesh Shirkhande, IN
  • Mohsen Mokhtar, EG
  • Bassim Al Bahrani, OM
  • Deborah Mukherji, LB
  • Pankaj Chaturvedi, IN
  • Zuhdi Khalid Nagshabandi, UAE
  • Maroun Khoury, UAE
  • Faraz Khan, UAE
  • Metab Al Foheidi, SA
  • Marwan Ghosn, LB
Deadlines ESMO Members ESMO Members in Training (under 40) Non Members (Physicians) Pharmacists & Industry Professionals Nurses
Including ESMO Nurses
Medical Students
Including ESMO
Medical Students
Undergraduates*
Early registration
Until 28 February 2018
500 USD 250 USD 650 USD 200 USD 60 USD 60 USD
Full registration
on or after March 1 or onsite
600 USD 350 USD 750 USD 300 USD 65 USD 65 USD

*Medical and science undergraduate students can benefit from free ESMO membership

Accreditation

The programme of this event has been accredited with 16 Cat.1 ESMO-MORA points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further information please refer to  ESMO-MORA Recertification Process & Requirements.

Contacts

CCM Middle East S.A.R.L
Rabieh Bikfaya Main Road
BLF Building, 2nd floor
Beirut, Lebanon
Tel: +961 4 415 220/1/2/3
Fax: +961 4 415200
E-mail:  esmosummitdubai2018@groupccm.com